The next COVID challenge: Mass immunization
In the last few days, Pfizer BioNTech a German-U.S. company, and the U.S. company Moderna have separately announced that the COVID-19 vaccines they have been developing have proved ninety-five per cent effective. Both subsequently said that they will now apply…
Read More: The next COVID challenge: Mass immunization
Source: Virgin Islands Daily News